$2500 | Single User
$5000 | Site License
$7500 | Global License

Cerebral Aneurysms Global Clinical Trials Review, H2, 2018 [Report Updated: 31-12-2018]

Published by Global Data: 31 Dec 2018 | 230663 | In Stock

Introduction

Cerebral Aneurysms Global Clinical Trials Review, H2, 2018

Summary

GlobalData's clinical trial report, “Cerebral Aneurysms Global Clinical Trials Review, H2, 2018" provides an overview of Cerebral Aneurysms clinical trials scenario. This report provides top line data relating to the clinical trials on Cerebral Aneurysms. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Cerebral Aneurysms Global Clinical Trials Review, H2, 2018 [Report Updated: 31-12-2018]

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 4

    Report Guidance 5

    GlobalData Clinical Trials Report Coverage 6

    Clinical Trials by Region 7

    Clinical Trials and Average Enrollment by Country 8

    Top Countries Contributing to Clinical Trials in Asia-Pacific 11

    Top Five Countries Contributing to Clinical Trials in Europe 12

    Top Countries Contributing to Clinical Trials in North America 13

    Top Countries Contributing to Clinical Trials in Middle East and Africa 14

    Clinical Trials by G7 Countries: Proportion of Cerebral Aneurysms to Cardiovascular Clinical Trials 15

    Clinical Trials by Phase in G7 Countries 17

    Clinical Trials in G7 Countries by Trial Status 18

    Clinical Trials by E7 Countries: Proportion of Cerebral Aneurysms to Cardiovascular Clinical Trials 20

    Clinical Trials in E7 Countries by Trial Status 22

    Clinical Trials by Phase 23

    In Progress Trials by Phase 24

    Clinical Trials by Trial Status 25

    Clinical Trials by End Point Status 27

    Subjects Recruited Over a Period of Time 28

    Clinical Trials by Sponsor Type 29

    Prominent Sponsors 30

    Top Companies Participating in Cerebral Aneurysms Therapeutics Clinical Trials 31

    Prominent Drugs 32

    Clinical Trial Profile Snapshots 33

    Appendix 50

    Abbreviations 50

    Definitions 50

    Research Methodology 51

    Secondary Research 51

    About GlobalData 51

    Contact Us 52

    Source 52

List Of Tables
in Cerebral Aneurysms Global Clinical Trials Review, H2, 2018 [Report Updated: 31-12-2018]

List of Tables

Cerebral Aneurysms Therapeutics, Global, Clinical Trials by Region, 2018* 7

Cerebral Aneurysms Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9

Cerebral Aneurysms Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10

Cerebral Aneurysms Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2018* 11

Cerebral Aneurysms Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12

Cerebral Aneurysms Therapeutics Clinical Trials, North America, Top Countries, 2018* 13

Cerebral Aneurysms Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 14

Proportion of Cerebral Aneurysms to Cardiovascular Clinical Trials, G7 Countries (%), 2018* 16

Cerebral Aneurysms Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17

Cerebral Aneurysms Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19

Proportion of Cerebral Aneurysms to Cardiovascular Clinical Trials, E7 Countries (%), 2018* 21

Cerebral Aneurysms Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 22

Cerebral Aneurysms Therapeutics, Global, Clinical Trials by Phase, 2018* 23

Cerebral Aneurysms Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 24

Cerebral Aneurysms Therapeutics, Global, Clinical Trials by Trial Status, 2018* 26

Cerebral Aneurysms Therapeutics Clinical Trials, Global, by End Point Status, 2018* 27

Cerebral Aneurysms Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 28

Cerebral Aneurysms Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 29

Cerebral Aneurysms Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 30

Cerebral Aneurysms Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 31

Cerebral Aneurysms Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 32

List Of Figures, Charts and Diagrams
in Cerebral Aneurysms Global Clinical Trials Review, H2, 2018 [Report Updated: 31-12-2018]

List of Figures

Cerebral Aneurysms Therapeutics, Global, Clinical Trials by Region (%), 2018* 7

Cerebral Aneurysms Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Cerebral Aneurysms Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10

Cerebral Aneurysms Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2018* 11

Cerebral Aneurysms Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12

Cerebral Aneurysms Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13

Cerebral Aneurysms Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 14

Proportion of Cerebral Aneurysms to Cardiovascular Clinical Trials, G7 Countries (%), 2018* 15

Cerebral Aneurysms Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17

Cerebral Aneurysms Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18

Proportion of Cerebral Aneurysms to Cardiovascular Clinical Trials, E7 Countries (%), 2018* 20

Cerebral Aneurysms Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 22

Cerebral Aneurysms Therapeutics, Global, Clinical Trials by Phase (%), 2018* 23

Cerebral Aneurysms Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 24

Cerebral Aneurysms Therapeutics, Global, Clinical Trials by Trial Status, 2018* 25

Cerebral Aneurysms Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 28

Cerebral Aneurysms Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 29

Cerebral Aneurysms Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 30

Cerebral Aneurysms Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 31

Cerebral Aneurysms Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 32

GlobalData Methodology 51

Additional Details

Publisher

Global Data

Publisher Information

Reference

230663 | GDHC5527CTIDB

Number of Pages

52

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Cerebral Vasospasm Global Clinical Trials Review, H2, 2016
Cerebral Vasospasm Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report,...
17 Aug 2016 by Global Data USD $2,500 More Info
Cerebral Palsy Global Clinical Trials Review, H2, 2016
Cerebral Palsy Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report, “Ce...
17 Aug 2016 by Global Data USD $2,500 More Info
Cerebral Vasospasm Global Clinical Trials Review, H2, 2016
Cerebral Vasospasm Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report,...
17 Aug 2016 by Global Data USD $2,500 More Info
Cerebral Palsy Global Clinical Trials Review, H2, 2016
Cerebral Palsy Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report, “Ce...
17 Aug 2016 by Global Data USD $2,500 More Info
Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2016
Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial rep...
27 Jul 2016 by Global Data USD $2,500 More Info
Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2016
Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial rep...
27 Jul 2016 by Global Data USD $2,500 More Info
Cerebral Hypoxia Global Clinical Trials Review, H1, 2016
Cerebral Hypoxia Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report, “...
20 Apr 2016 by Global Data USD $2,500 More Info
Cerebral Hypoxia Global Clinical Trials Review, H1, 2016
Cerebral Hypoxia Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report, “...
20 Apr 2016 by Global Data USD $2,500 More Info
Cerebral Aneurysms Global Clinical Trials Review, H1, 2016
Cerebral Aneurysms Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report,...
20 Jan 2016 by Global Data USD $2,500 More Info
Cerebral Infarction (Brain Infarction) Global Clinical Trials Review, H2, 2015
Cerebral Infarction (Brain Infarction) Global Clinical Trials Review, H2, 2015SummaryGlobalData's cl...
16 Dec 2015 by Global Data USD $2,500 More Info

This report is published by Global Data

Download Free Report Summary PDF

Cerebral Aneurysms Global Clinical Trials Review, H2, 2018 [Report Updated: 31-12-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data